Stay updated on Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page
- Check7 days agoChange DetectedThe footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe revision label in the footer changes from v3.7.0 to v3.7.1; the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe study details page now displays a 403 Forbidden page, replacing the previous content. This blocks access to the study record and its details.SummaryDifference0.5%

- Check35 days agoChange DetectedThe page now renders a 403 Forbidden error instead of displaying the study details, effectively blocking access to the study record. The layout still shows the site header and footer, indicating a standard error response rather than the study content.SummaryDifference21%

- Check56 days agoChange DetectedRevision: v3.6.6 replaces the previous revision label. It indicates a small update to the site's documentation or interface.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now includes new study documents and metadata, such as the Informed Consent Form and Study Protocol/Statistical Analysis Plan, plus author/sponsor details and NIH/NCI links, with associated MeSH terms and record history.SummaryDifference63%

Stay in the know with updates to Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Soft Tissue Sarcoma Clinical Trial page.